Latest News

Bioventus launches OSTEOMATRIX biphasic bone graft

  Bioventus has launched OSTEOMATRIX+, a biphasic bone graft for use in bone remodelling in a variety of orthopaedic and spine applications. OSTEOMATRIX+ is a mouldable bone graft substitute...


N20: Spine in the spotlight at global meeting

The Society for Brain Mapping and Therapeutics (SBMT) and the Brain Mapping Foundation (BMF) recently hosted their 5th Annual Neuroscience-20 event in Buenos Aires,...

Combating the rise in predatory publishing

“Dear Distinguished Professor, we invite you to submit...” Christopher M Bono warns of the rise in predatory publishing, drawing on his own experiences of...


Level 1 evidence, presented at EUROSPINE 2018 in Barcelona, Spain, demonstrates that i-FACTOR peptide enhanced bone graft results in significantly higher rates of fusion in uninstrumented lumbar spinal surgery than does the use of allograft. Michael Jacobsen (Middelfart, Denmark) spoke...


Donna Ohnmeiss

Frank Kandziora

Frank Kandziora

Raja Rampersaud

(Visited 26,702 times, 79 visits today)